C
Covenant Metabolic Specialists | University Park, FL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
NNC0194-0499
MK-7240
Tirzepatide
Retatrutide
Tulisokibart
Cagrilintide
MK-7240-008
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in...
Enrolling
Metabolic Dysfunction-Associated Steatotic Liver Disease
Drug: Tirzepatide
Drug: Placebo
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's diseas...
Enrolling
Crohn's Disease
Other: SC Placebo
Drug: IV Tulisokibart
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems